A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER. Asian J. Med. Res. Health Sci. [Internet]. 2026 Feb. 20 [cited 2026 Feb. 20];4(1):203-8. Available from: http://www.ajmrhs.com/index.php/journal/article/view/179